Resection margin involvement after endoscopic excision of malignant colorectal polyps: definition of margin involvement and its impact upon tumour recurrenceHISTOPATHOLOGYIF4.12023-03-204OA
Derivation and validation of a novel method to subgroup patients with functional dyspepsia: beyond upper gastrointestinal symptomsALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72020-12-0514PRE
Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectinTHERAPEUTIC ADVANCES IN GASTROENTEROLOGYIF3.42018-01-1813OAAI
Making a positive diagnosis of irritable bowel syndromeBRITISH JOURNAL OF GENERAL PRACTICEIF5.22017-11-305OAAI
Need for Caution in Diagnosis of Irritable Bowel Syndrome in Patients With Inflammatory Bowel Disease ReplyCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122017-08-010OAAI
Cyclic vomiting syndrome is a prevalent and under-recognized condition in the gastroenterology outpatient clinicNEUROGASTROENTEROLOGY AND MOTILITYIF2.92017-07-2633OAAI
Editorial: latent class analysis to improve confidence in the diagnosis of IBS - authors' replyALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72017-04-030OAAI
Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel DiseaseCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122017-03-0189OAAI
Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysisLANCET GASTROENTEROLOGY & HEPATOLOGYIF38.62017-03-01162OAAI
Risk of gastrointestinal bleeding with direct oral anticoagulants: a systematic review and network meta-analysisLANCET GASTROENTEROLOGY & HEPATOLOGYIF38.62017-02-0136OAAI
Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysisALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72017-01-209OAAI
Editorial: volatile organic compounds in irritable bowel syndrome - technology for an accurate and reliable point-of-care test?ALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72017-01-101OAAI
The relationship between different information sources and disease-related patient knowledge and anxiety in patients with inflammatory bowel diseaseALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72016-10-2536OAAI
Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic EvaluationAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62016-10-0142OAAI
Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel DiseaseAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62016-04-01122OAAI
Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the PastCLINICAL AND TRANSLATIONAL GASTROENTEROLOGYIF32015-10-014OAAI
Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markersALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72015-06-1566OAAI
Long-term Efficacy and Safety of Azathioprine in Ulcerative ColitisJOURNAL OF CROHNS & COLITISIF8.72014-12-0325OAAI
Earlier Use of Azathioprine in Ulcerative Colitis Does Not Alter Subsequent Need for Hospitalisation, Biologic Therapy, or ColectomyGASTROENTEROLOGYIF25.12014-05-011PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向